Treatment with growth factors is an
effective method to promote wound healing. Several growth factors have been
used in wound treatment, including basic fibroblast growth factor (bFGF)
discovered in the 1970s, platelet-derived growth factor (PDGF), epidermal
growth factor (EGF), and bone morphogenetic protein (BMP). In 2001, Kaken Pharmaceutical Co., Ltd. launched Fiblast Spray
This product is a topical formulation containing recombinant human bFGF. It is
used to treat decubitus ulcers and skin ulcers (burn ulcers and leg ulcers).
There is increasing interest in its stimulatory effect on wound healing and its
inhibitory effect on scar formation.Wound healing is a physiological phenomenon that involves a complex series
of integrated cellular and biochemical responses, characterized by phases of
hemostasis, inflammation, proliferation, and maturation. However, much of its
detailed mechanism remains unknown. There have been many basic research studies
on wound healing using cells and experimental animals. If findings can be used
from such studies and clinical practice, development of even more effective
treatments might be possible.
Cite this paper
K. Okabe, R. Hayashi, N. Aramaki-Hattori, Y. Sakamoto and K. Kishi, "Wound Treatment Using Growth Factors," Modern Plastic Surgery, Vol. 3 No. 3, 2013, pp. 108-112. doi: 10.4236/mps.2013.33022.
 D. Gospodarowicz, “Localisation of a Fibroblast Growth Factor and Its Effect Alone and with Hydrocortisone on 3T3 Cell Growth,” Nature, Vol. 249, 1974, pp. 123-127.
 R. Ross, J. Glomset, B. Kariya, et al., “A Platelet-Dependent Serum Factor That Stimulates the Proliferation of Arterial Smooth Muscle Cells in Vitro,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 71, No. 4, 1974, pp. 1207-1210.
 S. Cohen, “Isolation of a Mouse Submaxillary Gland Protein Accelerating Incisor Eruption and Eyelid Opening in the New-Born Animal,” Journal of Biological Chemistry, Vol. 237, 1962, pp. 1555-1562.
 M. R. Urist, “Bone: Formation by Auto Induction,” Science, Vol. 150, No. 3698, 1965, pp. 893-899.
 S. Ortega, M. Ittmann, S. H. Tsang, et al., “Neuronal Defects and Delayed Wound Healing in Mice Lacking Fibroblast Growth Factor 2,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 95, No. 10, 1998, pp. 5672-5677.
 G. S. McGee, J. M. Davidson, A. Buckley, et al., “Recombinant Basic Fibroblast Growth Factor Accelerates Wound Healing,” Journal of Surgical Research, Vol. 45, No. 1, 1988, pp. 145-153.
 P. A. Hebda, C. K. Klingbeil, J. A. Abraham, et al., “Basic Fibroblast Growth Factor Stimulation of Epidermal Wound Healing in Pigs,” Journal of Investigative Dermatology, Vol. 95, 1990, pp. 626-631.
 R. Tsuboi and D. B. Rifkin, “Recombinant Basic Fibroblast Growth Factor Stimulates Wound Healing in Healing-Impaired db/db Mice,” Journal of Experimental Medicine, Vol. 172, No. 1, 1990, pp. 245-251.
 S. Kanazawa, T. Fujiwara, S. Matsuzaki, et al., “bFGF Regulates PI3-Kinase-Rac1-JNK Pathway and Promotes Fibroblast Migration in Wound Healing,” PLoS ONE, Vol. 5, No. 8, 2010, Article ID: e12228.
 Y. Akasaka, I. Ono, T. Kamiya, et al., “The Mechanisms Underlying Fibroblast Apoptosis Regulated by Growth Factors during Wound Healing,” Journal of Pathology, Vol. 221, No. 3, 2010, pp. 285-299.
 S. Akita, K. Akino, T. Imaizumi, et al., “A Basic Fibroblast Growth Factor Improved the Quality of Skin Grafting in Burn Patients,” Burns, Vol. 31, No. 7, 2005, pp. 855-858. doi:10.1016/j.burns.2005.04.008
 S. Akita, K. Akino, T. Imaizumi, et al., “The Quality of Pediatric Burn Scars Is Improved by Early Administration of Basic Fibroblast Growth Factor,” Journal of Burn Care & Research, Vol. 27, No. 3, 2006, pp. 333-338.
 T. Uemura, H. Watanabe and Y. Uemura, “Clinical Use of Trafermin (Fiblast Spray) in Pediatric Outpatients with Burn Injuries,” Japanese Journal of Burn Injuries, Vol. 32, No. 5, 2006, pp. 291-297.
 I. Ono, Y. Akasaka, R. Kikuchi, et al., “Basic Fibroblast Growth Factor Reduces Scar Formation in Acute Incisional Wounds,” Wound Repair and Regeneration, Vol. 15, No. 5, 2007, pp. 617-623.
 H. Eto, H. Suga, N. Aoi, et al., “Therapeutic Potential of Fibroblast Growth Factor-2 for Hypertrophic Scars: Upregulation of MMP-1 and HGF Expression,” Laboratory Investigation, Vol. 92, No. 2, 2012, pp. 214-223.
 A. Sugamata, N. Yoshizawa and S. Oyama, “Treatment of Fingertip Amputation Using a Combination of Artificial Dermis and bFGF Formulation,” Progress in Medicine, Vol. 26, 2006, pp. 2731-2735.
 K. Kawai, S. Suzuki, Y. Tabata, et al., “Accelerated Tissue Regeneration through Incorporation of Basic Fibroblast Growth Factor-Impregnated Gelatin Microspheres into Artificial Dermis,” Biomaterials, Vol. 21, No. 5, 2000, pp. 489-499. doi:10.1016/S0142-9612(99)00207-0
 N. Kanda, N. Morimoto, S. Takemoto, et al., “Efficacy of Novel Collagen/Gelatin Scaffold with Sustained Release of Basic Fibroblast Growth Factor for Dermis-Like Tissue Regeneration,” Annals of Plastic Surgery, Vol. 69, No. 5, 2012, pp. 569-574.
 N. Kanda, N. Morimoto, A. A. Ayvazyan, et al., “Evaluation of a Novel Collagen-Gelatin Scaffold for Achieving the Sustained Release of Basic Fibroblast Growth Factor in a Diabetic Mouse Model,” Journal of Tissue Engineering and Regenerative Medicine, 2012.
 H. Kawaguchi, S. Jinguchi, T. Izumi, et al., “Local Application of Recombinant Human Fibroblast Growth Factor-2 on Bone Repair: A Dose-Escalation Prospective Trial on Patients with Osteotomy,” Journal of Orthopaedic Research, Vol. 25, No. 4, 2007, pp. 480-487.
 M. Kitamura, K. Nakashima, Y. Kowashi, et al., “Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2: Randomized Controlled Phase II Clinical Trial,” PLoS ONE, Vol. 3, No. 7, 2008, Article ID: e2611.
 M. Kitamura, M. Akamatsu, M. Machigashira, et al., “FGF-2 Stimulates Periodontal Regeneration: Results of a Multi-Center Randomized Clinical Trial,” Journal of Dental Research, Vol. 90, No. 1, 2011, pp. 35-40.